Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bris...
Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers Squibb by striking a broad pact that positions...
Author: Fierce Biotech
Read Original Article